ClinicalTrials.Veeva

Menu

Effectiveness of Rebound Therapy in Parkinson's Patients

G

Gazi University

Status

Completed

Conditions

Parkinson Disease

Treatments

Other: Rebound therapy
Other: Exercises on a stable surface

Study type

Interventional

Funder types

Other

Identifiers

NCT05855161
5-PD-Rebound therapy-RCT

Details and patient eligibility

About

Today, physiotherapy approaches in Parkinson's Disease (PD) form the basis of optimal treatment together with medical and surgical treatment. It is stated that various rehabilitation interventions may be effective in the field of physiotherapy. The frequently preferred among these rehabilitation interventions is the conventional treatment approach. In the conventional treatment, various exercises are preferred to improve balance and walking, as well as stretching and strengthening. On the other hand, rebound therapy require strong integration of the neuromuscular system and provide more active use of lower extremity muscle strength. Rebound therapy have been shown to be effective in improving balance in many neurological disease groups, but there is very little study on rebound therapy in PD. It was shown that rebound therapy improve proprioceptive sense, joint range of motion and quality of life. On the other hand, no study has been found showing its effect on balance and walking. Therefore, there is a need to investigate the effectiveness of rebound therapy on balance and walking.

Full description

This study is a randomized controlled study. The patients will be randomly divided into two groups as rebound and control. The rebound group will perform exercises on a trampoline, consisting of 15 minutes of trunk and extremity stretching, 10 minutes of walking, and approximately 30 minutes of task-oriented exercises, twice a week for six weeks. While the control group will follow the same program as the rebound group, they will only perform task-oriented exercises on a stable surface, unlike the rebound group. As the outcome measures, disease severity and disability, balance, and gait performance will be evaluated.

Enrollment

17 patients

Sex

All

Ages

40 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 40-80 years of age
  • Having diagnosed with "Parkinson's Disease" by a specialist physician
  • Having between 1-3 stages according to the Hoehn and Yahr Scale
  • Mini-Mental Test score more than or equal 24

Exclusion criteria

  • Any orthopedic, vision, hearing, cardiovascular, or perception problems that may affect the research results

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

17 participants in 2 patient groups

Rebound therapy
Experimental group
Description:
The group that will perform exercises on a trampoline.
Treatment:
Other: Rebound therapy
Control group
Experimental group
Description:
The group that will perform exercises on a stable surface.
Treatment:
Other: Exercises on a stable surface

Trial contacts and locations

1

Loading...

Central trial contact

Sefa Eldemir, PT,PhD.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems